Skip to main content

AHRQ's National Guideline Clearinghouse is a public resource for summaries of evidence-based clinical practice guidelines.

January 16, 2017

Guideline Summaries

  • New American Academy of Orthopaedic Surgeons Guidelines on:
    • Treatment of Anterior Cruciate Ligament Injuries
    • Management of Osteochondritis Dissecans of the Femoral Condyle
  • Updated Institute for Clinical Systems Improvement Guidelines on:
    • Healthy Lifestyles
    • Adult Depression in Primary Care

View All New This Week

January 16, 2017

U.S. FDA Advisory

FDA Advisory

December 16, 2016: Chantix (varenicline) and Zyban (bupropion) External Web Site Policy: Based on an FDA review of a large clinical trial that FDA required the drug companies to conduct, FDA determined the risk of serious side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) is lower than previously suspected. The risk of these mental health side effects is still present, especially in those currently being treated for mental illnesses such as depression, anxiety disorders, or schizophrenia, or who have been treated for mental illnesses in the past. However, most people who had these side effects did not have serious consequences such as hospitalization. The results of the trial confirm that the benefits of stopping smoking outweigh the risks of these medicines.

Conference News

Conference News

Registration is now open External Web Site Policy for the Evidence-based Guidelines Affecting Policy, Practice and Stakeholders (E-GAPPS III) Conference. It will be held March 20-21, 2017 at The New York Academy of Medicine.

View All Announcements

About NGC

NGC supports AHRQ's mission to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable by providing objective, detailed information on clinical practice guidelines, and to further their dissemination, implementation, and use in order to inform health care decisions.